Accueil
Marchés
Graphique & Idées
Algo
Nouvelles
Store
Courtiers
Télécharger
Calendrier Economique
Signaux de trading
Terminal Web
Heatmap
Tapez
/
pour rechercher : @user, $symbol
Recherche
Se connecter
Créer un compte
Français
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Italiano
Türkçe
RXST
#3384
RxSight, Inc. Common Stock
7.2
2
USD
-0.69%
Secteur:
Soins de Santé
Base:
USD
Devise de Profit:
USD
Range quotidien
Range Annuel
Changement quotidien
-0.69%
Changement Mensuel
-3.09%
Evolution sur 6 mois
-9.75%
Changement Annuel
-50.95%
Clôture Précédente
7.2
7
Open
7.2
2
Bid
Ask
Low
7.2
2
High
7.2
2
Volume
54
Marchés
Actions des Marchés US
Soins de Santé
RXST
Open full chart
Financials
Overview
Relevé
Statistics
Quarterly
Annual
Value
Q4, 24
Q1, 25
Q2, 25
Q3, 25
Q4, 25
TTM
Key stats
Total common shares outstanding
40.49 M
40.64 M
40.92 M
41.12 M
41.27 M
—
Valuation ratios
Enterprise value
1.38 B
998.08 M
491.55 M
340.01 M
410.05 M
2.24 B
Price to earnings ratio
-48.42
-38.26
-16.46
-10.33
-10.97
-76.02
Price to sales ratio
9.55
6.71
3.53
2.54
3.17
15.94
Price to cash flow ratio
-78.85
-60.7
-31.05
-19.37
-27.44
-138.56
Price to book ratio
4.75
0.89
0.47
0.32
1.54
3.23
Enterprise value to EBITDA ratio
-41.28
-29.63
-12.48
-7.98
-9.12
-59.22
Profitability ratios
Return on assets %
-0.02
-0.03
-0.04
-0.03
-0.03
-0.13
Return on equity %
-0.02
-0.03
-0.04
-0.04
-0.03
-0.14
Return on invested capital %
-55.23
-64.3
-72.57
-62.59
-66.59
-266.05
Gross margin %
71.59
74.76
74.89
79.85
77.48
306.97
Operating margin %
-21.46
-28.17
-41.63
-40.14
-34.77
-144.7
EBITDA margin %
-20.18
-26.17
-39.33
-37.32
-32.16
-134.98
Net margin %
-14.77
-21.61
-35.04
-32.35
-28.07
-117.07
Liquidity ratios
Quick ratio
10.5
11.65
12.7
11.44
9.75
45.53
Current ratio
11.36
12.68
13.93
12.74
10.95
50.29
Inventory turnover
0.52
0.42
0.35
0.23
0.24
1.24
Asset turnover
0.13
0.12
0.11
0.1
0.11
0.43
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
Long term debt to total assets ratio
—
—
—
—
—
—
Long term debt to total equity ratio
—
—
—
—
—
—
Per share metrics
Operating cash flow per share
-0.11
-0.22
-0.11
-0.03
-0.03
-0.38
EBIT per share
-0.22
-0.26
-0.34
-0.3
-0.28
-1.18
EBITDA per share
-0.21
-0.24
-0.32
-0.28
-0.26
-1.1
Total debt per share
—
—
—
—
—
—
Cash per share
6.1
5.66
5.58
5.55
5.58
22.38
Net current asset value per share
7.56
7.12
6.97
6.93
7.04
28.05
Tangible book value per share
7.24
6.9
6.82
6.74
6.75
27.2
Working capital per share
6.89
6.56
6.47
6.39
6.39
25.81
Book value per share
7.24
6.9
6.82
6.74
6.75
27.2
Nouvelles
RxSight franchit le cap des 300.000 implants de lentilles ajustables à la lumière
Stifel réduit l’objectif de cours de RxSight à 9$
Stifel cuts RxSight stock price target to $9 on revenue guidance
Needham reiterates Buy on RxSight stock, keeps $13 target
RxSight, Inc. (RXST) Q4 2025 Earnings Call Transcript
RxSight, Inc. (RXST) Reports Q4 Loss, Beats Revenue Estimates
Le BPA de Rxsight a dépassé les attentes de 0,32$, le CA a surpassé les prévisions
Rxsight earnings beat by $0.32, revenue topped estimates
Alphatec (ATEC) Q4 Earnings and Revenues Beat Estimates
Earnings Preview: Teleflex (TFX) Q4 Earnings Expected to Decline
Earnings Preview: RxSight, Inc. (RXST) Q4 Earnings Expected to Decline
RxSight stock initiated with Market Perform rating by William Blair